Tag: FDA generic drug surveillance
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA monitors generic drugs after approval using real-time data systems like FAERS and Sentinel to catch safety issues that clinical trials miss. Learn how adverse event reports, inspections, and AI tools keep millions of patients safe.
